NICE recommends gene therapy for inherited retinal dystrophy
Draft guidance from the National Institute for Health and Care Excellence (NICE) has recommended licensed gene therapy for people with vision loss caused by RPE65 mediated inherited retinal dystrophy…
Read Original Article: NICE recommends gene therapy for inherited retinal dystrophy »
